<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0123-9392</journal-id>
<journal-title><![CDATA[Infectio]]></journal-title>
<abbrev-journal-title><![CDATA[Infect.]]></abbrev-journal-title>
<issn>0123-9392</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Infectología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0123-93922017000300141</article-id>
<article-id pub-id-type="doi">10.22354/in.v21i3.670</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo para el desarrollo de infección de vías urinarias por microorganismos productores de betalactamasas de espectro extendido adquiridos en la comunidad, en dos hospitales de Bogotá D.C., Colombia]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors for the development of community-acquired urinary tract infection, by extended-spectrum beta-lactamase producing microorganisms, at two hospitals in Bogotá, Colombia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pineda-Posada]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[Gerson]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Suárez-Obando]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bastidas]]></surname>
<given-names><![CDATA[Alirio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ávila-Cortés]]></surname>
<given-names><![CDATA[Yeisson]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la Sabana  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Fundación Clínica Shaio  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Santa Clara  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<numero>3</numero>
<fpage>141</fpage>
<lpage>147</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0123-93922017000300141&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0123-93922017000300141&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0123-93922017000300141&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Abstract  Objetivo:  Determinar factores de riesgo para infección urinaria por microorganismos productores de betalactamasas de espectro extendido (BLEE) adquirida en la comunidad en pacientes adultos.  Material y método:  Estudio de casos y controles, en el período comprendido entre enero de 2012 a mayo de 2015, en dos hospitales de Bogotá D.C., Colombia. Pareo por edad, año del aislamiento, microorganismo y género. Se excluyeron pacientes con antecedente de infección por un microorganismo productor de BLEE en el último mes e infección urinaria asociada al cuidado de la salud.  Resultados:  Se analizaron 555 pacientes: 185 casos y 370 controles. 462 pacientes (83,2%) de la Fundación Clínica Shaio y 93 (16,8%) del Hospital Santa Clara. Factores de riesgo identificados: Infección urinaria recurrente (OR 2,13 con IC de 1,48 a 3,07), enfermedad renal crónica (OR 1,56, IC del 95% de 1,07 a 2,27), uso previo de antibióticos (OR 3,46, IC del 95% de 2,48 a 5,35), hospitalización reciente (OR 3,0, IC del 95% de 1,96 a 2,45), diabetes mellitus (OR 1,61 con IC del 95% de 1,06 a 2,45) e infección urinaria alta (OR 2,64 con IC del 95% de 1,61 a 4,32).  Conclusiones:  Los factores de riesgo para microorganismos productores de BLEE adquiridos en la comunidad fueron en orden de frecuencia: antecedente de antibioticoterapia reciente, hospitalización previa, presencia de infección urinaria alta, así como los antecedentes de infección urinaria recurrente, enfermedad renal crónica y diabetes mellitus, lo que concuerda con los principales hallazgos descritos en la literatura mundial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Resumen  Aims:  To determine risk factors for the development of community-acquired urinary tract infection, by extended-spectrum beta-lactamase producing microorganisms, in adult patients.  Materials and methods:  A case-control study in the period from January 2012 to May 2015, in two hospitals in Bogota, Colombia. Matching for age, year of isolation, microorganism and gender. We excluded patients with a history of infection with extended-spectrum beta-lactamase producing microorganisms in the last month and urinary infection associated with health care.  Results:  555 patients were analyzed.185 cases and 370 controls. 462 patients (83.2%) from Fundación Clínica Shaio and 93 (16.8%) from Hospital Santa Clara. Identified risk factors: recurrent urinary tract infection (OR= 2.13, 95% CI= 1.48 - 3.07), chronic kidney disease (OR= 1.56, 95% CI= 1.07 - 2.27), previous use of antibiotics (OR= 3.46, 95% CI= 2.48 - 5.35), recent hospitalization (OR= 3.0, 95% CI= 1.96 to 2.45), diabetes mellitus (OR= 1.61, 95% CI= 1.06 - 2.45) and upper urinary tract infection (OR= 2.64, 95% CI= 1.61 - 4.32).  Conclusions: The risk factors community-acquired urinary tract infection, by extended-spectrum beta-lactamase producing microorganisms, were in order of frequency: history of recent antibiotic therapy, prior hospitalization, the presence of high urinary infection, history of recurrent urinary tract infection, chronic kidney disease and diabetes mellitus. The described risk factors are consistent with the main findings described in the literature.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[infección urinaria]]></kwd>
<kwd lng="es"><![CDATA[adquirida en la comunidad]]></kwd>
<kwd lng="es"><![CDATA[BLEE]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[Urinary tract infection]]></kwd>
<kwd lng="en"><![CDATA[Community-Acquired Infections]]></kwd>
<kwd lng="en"><![CDATA[ESBL]]></kwd>
<kwd lng="en"><![CDATA[risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitout]]></surname>
<given-names><![CDATA[J.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Laupland]]></surname>
<given-names><![CDATA[K.B]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2008</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>159-66</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitout]]></surname>
<given-names><![CDATA[J.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Drugs]]></source>
<year>2010</year>
<volume>70</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>313-33</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Extended-spectrum beta-lactamases: a clinical update]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paterson]]></surname>
<given-names><![CDATA[D.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonomo]]></surname>
<given-names><![CDATA[R.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Microbiol Rev]]></source>
<year>2005</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>657-86</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ESBLs: A Clear and Present Danger?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dhillon]]></surname>
<given-names><![CDATA[R. H]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Crit Care Res Pract]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>625170</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Escherichia coli portador de betalactamasas de espectro extendido: resistencia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Sanid. Mil]]></source>
<year>2013</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>244-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Identificación de betalactamasas de espectro extendido en enterobacterias]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev haban cienc méd]]></source>
<year>2010</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>516-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruppe]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2009</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>741-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Garzon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2012</year>
<volume>16</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>420-5</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ben-Ami]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2009</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>682-90</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<collab>CLSI, Clinical and Laboratory Standards Insitute</collab>
<source><![CDATA[Performance Standards for Antimicrobial Susceptebility Testing: Twentieth Informational Supplement M100-S20]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Wayne, PA, USA ]]></publisher-loc>
<publisher-name><![CDATA[CLSI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[M.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Antimicrob Agents Chemother]]></source>
<year>1979</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>190-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[WHONET: an information system for monitoring antimicrobial resistance]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[T.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Stelling]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>1995</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>66</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Talbot]]></surname>
<given-names><![CDATA[G.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2006</year>
<volume>42</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>657-68</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiology and risk factors of community-onset rinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kung]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Microbiol Immunol Infect]]></source>
<year>2015</year>
<volume>48</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramadas]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2014</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e91289</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae-a case-control study in a low prevalence country]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soraas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2013</year>
<volume>8</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>e69581</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[[Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia]]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2013</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>298-303</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Identifying patients harboring extended-spectrumbeta- lactamase-producing Enterobacteriaceae on hospital admission derivation and validation of a scoring system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tumbarello]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Antimicrob Agents Chemother]]></source>
<year>2011</year>
<volume>55</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>3485-90</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados al aislamiento de scherichia coli o Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en un hospital de cuarto nivel en Colombia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Biomédica]]></source>
<year>2014</year>
<volume>34</volume>
<page-range>16-22</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gruber]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Med Microbiol]]></source>
<year>2013</year>
<volume>303</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>405-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Extended-spectrum beta-lactamase-producing Enterobacteriaceae in French nursing homes: an association between high carriage rate among residents, environmental contamination, poor conformity with good hygiene practice, and putative resident-to-resident transmission]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cochard]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Infect Control Hosp Epidemiol]]></source>
<year>2014</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>384-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Detection of virulence genes in Escherichia coli isolated frompatients with cystitis and pyelonephritis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Firoozeh]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Infect Dis]]></source>
<year>2014</year>
<volume>29</volume>
<page-range>219-22</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Urinary tract infections: current and emerging management strategies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barber]]></surname>
<given-names><![CDATA[A.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2013</year>
<volume>57</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>719-24</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
